Quest Diagnostics Inc vs McCormick & Company, Incorporated — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while McCormick & Company, Incorporated trades at $52.73 (market cap $14.22B). The key difference: Quest Diagnostics Inc is the larger of the two by market cap, and McCormick & Company, Incorporated pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| DGX | MKC | |
|---|---|---|
Market Cap | $26.21B | $14.22B |
Sector | Health | Consumer Staples |
52-Week High | $238.50 | $72.26 |
52-Week Low | $173.49 | $45.60 |
Enterprise Value | $31.97B | $18.82B |
Dividend Yield | 1.45% | 3.63% |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →